Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

"…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides حسب Zufang Ba (11036420)

"…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …"

Significant associations in GWAS. حسب Dai Nogimura (21445649)

"…<div><p>Decreased nitric oxide (NO) production from the vascular endothelium is a major factor for vascular aging. …"

Demonstration of decreased Aβ accumulation by DA-9601 treatment. حسب Mijung Lee (397790)

VP16 protein abundance is decreased at low MOI in the ΔCTRL2 recombinant virus. حسب Pankaj Singh (116938)

Schematic diagram of the molecular mechanism by which TRIM37 improves MS by stabilizing PEX5 through monoubiquitination. حسب Lai Jiang (2401513)

الموضوعات:

BT9 did not improve survival in the orthotopic xenograft model of D425 medulloblastoma. حسب Zahra Motahari (6814013)

الموضوعات:

P values of Kruskal–Wallis test at 95% significance level. حسب Fahd Saeed Alakbari (10701871)

الموضوعات:

Frontier Analysis: Countries with high potential for improvement in the burden of injuries caused by fire, heat, and hot substances in 2021. حسب Shi Huang (125861)

Significant Wilcoxon test results of the Task 1 Nasa TLX data, differences between feedback ON and OFF. حسب Mucahit Gemici (21519313)

Supplementary data on the link between Hdc and ROS in the PSC. حسب Bayan Kharrat (19959505)

Grading standards for improved water boiling method. حسب Ying Fang (147352)

الموضوعات:

Lys823 in NLRP3 is essential for its K27-linked ubiquitination and autophagic degradation. حسب Huaji Jiang (16907514)

VANGL2 recruits MARCH8 to promote the K27-linked ubiquitination of NLRP3. حسب Huaji Jiang (16907514)